US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Serina Therapeutics, Inc.

2.87

+0.22008.30%

Post-market: 2.80-0.0700-2.44%19:30 EDT

Volume:46.11K

Turnover:128.72K

Market Cap:72.90M

PE:-1.49

High:2.87

Open:2.67

Low:2.62

Close:2.65

52wk High:7.92

52wk Low:1.22

Shares:25.40M

Float Shares:12.51M

Volume Ratio:0.52

T/O Rate:0.37%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9304

EPS(LYR):-1.9100

ROE:-207.94%

ROA:-92.30%

PB:3.89

PE(LYR):-1.50

Loading ...

Overview Company News Filings

Serina Therapeutics: Buy Rating Reiterated, $11 Price Target Maintained on Strong SER-252 Clinical Progress

Serina Therapeutics, Inc Q2 Operating Expenses USD 6.784 Million

THOMSON REUTERS

Serina Therapeutics Q2 FY26 Net Loss Narrows to $6.36 Million; Revenue Falls to no Grant Revenue

Serina Therapeutics Posts Investor Deck Outlining POZ Platform, Lead Parkinson’s Candidate Ser-252 Phase 1b Study

Serina Therapeutics to Join BTIG Virtual Biotechnology Conference Investor Meetings

Serina Therapeutics Director Simon Farrell Files Initial Beneficial Ownership Statement

Serina Therapeutics CEO Steve Ledger Base Salary Rises to $500,000 Under Amended Employment Deal

Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of Ser-252 for Advanced Parkinson’s Disease

THOMSON REUTERS

Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson’s Disease

Serina Therapeutics Appoints Trevi CCO Farrell Simon to Board

Serina Therapeutics Appoints Farrell Simon to Its Board of Directors

THOMSON REUTERS

Serina Says Panel Clears Dosing More Patients in Phase 1b Trial of SER-252 in Parkinson's Disease

MT Newswires Live

Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1B Registrational Trial of Ser-252 for Advanced Parkinson’s Disease

THOMSON REUTERS

Serina Therapeutics Director Stephen K. Brannan Acquires 1,000 Common Shares Worth $2,030

Seres Therapeutics' Phase 1 Trial of SER-155 Meets Primary Endpoint; Shares Rise Pre-Bell

MT Newswires Live

Seres Therapeutics announces top-line results from SER-155 trial

Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment

Sumitomo Backs $1m Exploration Push at SER’s Bulimba Gold Project

Serina Therapeutics initiated with a Buy at BTIG

Gannet Biochem and Serina Therapeutics Enter Development Partnership Supporting Ser-252 Program

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/SER/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SER","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SER\",,,,,undefined,":{"symbol":"SER","market":"US","secType":"STK","nameCN":"Serina Therapeutics, Inc.","latestPrice":2.87,"timestamp":1787342400000,"preClose":2.65,"halted":0,"volume":46107,"hourTrading":{"tag":"盘后","latestPrice":2.8,"preClose":2.87,"latestTime":"19:30 EDT","volume":597,"amount":1675.1805,"timestamp":1787355006161,"change":-0.07,"changeRate":-0.02439,"amplitude":0.02439},"delay":0,"changeRate":0.08301886792452838,"floatShares":12506764,"shares":25400500,"eps":-1.93037,"marketStatus":"Market Closed","change":0.22,"latestTime":"08-21 16:00:00 EDT","open":2.67,"high":2.87,"low":2.6181,"amount":128724.73164720001,"amplitude":0.095057,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.93037,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"AMEX","adjPreClose":2.65,"postHourTrading":{"tag":"盘后","latestPrice":2.8,"preClose":2.87,"latestTime":"19:30 EDT","volume":597,"amount":1675.1805,"timestamp":1787355006161,"change":-0.07,"changeRate":-0.02439,"amplitude":0.02439},"volumeRatio":0.5182926135679764},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SER\",,,,,undefined,":{"symbol":"SER","floatShares":12506764,"roa":"-92.30%","roe":"-207.94%","lyrEps":-1.91,"volumeRatio":0.5182926135679764,"shares":25400500,"dividePrice":0,"high":2.87,"amplitude":0.095057,"preClose":2.65,"low":2.6181,"week52Low":1.22,"pbRate":"3.89","week52High":7.92,"institutionHeld":0,"latestPrice":2.87,"eps":-1.93037,"divideRate":0,"volume":46107,"delay":0,"ttmEps":-1.93037,"open":2.67,"prevYearClose":1.913,"prevWeekClose":2.8,"prevMonthClose":2,"prevQuarterClose":1.94,"fiveDayClose":2.8,"twentyDayClose":2.07,"sixtyDayClose":1.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SER\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"SER","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.55},{"market":"US","date":"2026-05-14","symbol":"SER","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2026-03-25","symbol":"SER","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2025-11-13","symbol":"SER","fiscalQuarterEnding":"2025/09","expectedEps":-0.47,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-08-11","symbol":"SER","fiscalQuarterEnding":"2025/06","expectedEps":-0.36,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.66}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SER\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SER\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1782964800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SER\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SER","date":"2026-08-21","current":-1.486762,"percent":0.611015,"low":-65.600015,"twenty":-9.673416,"median":-4.399188,"eighty":-1.335413,"high":37.356482,"avg":-9.395334,"sd":19.123485,"marketCap":67311253},"quantilePoints":[{"date":"2024-04-05","current":29.141387,"twenty":30.584579,"median":32.083279,"eighty":33.732959,"marketCap":105541506},{"date":"2024-04-12","current":17.770243,"twenty":17.783016,"median":23.543628,"eighty":32.232039,"marketCap":93646584},{"date":"2024-04-19","current":17.456349,"twenty":17.731924,"median":17.945869,"eighty":31.172957,"marketCap":91992413},{"date":"2024-04-26","current":14.673941,"twenty":16.787882,"median":17.778226,"eighty":29.502185,"marketCap":77329529},{"date":"2024-05-03","current":14.209648,"twenty":14.673941,"median":17.57865,"eighty":21.283439,"marketCap":74882770},{"date":"2024-05-10","current":14.050147,"twenty":14.209648,"median":17.078432,"eighty":18.800885,"marketCap":74042223},{"date":"2024-05-17","current":12.820759,"twenty":14.187327,"median":15.966076,"eighty":18.090969,"marketCap":67563528},{"date":"2024-05-24","current":15.167772,"twenty":14.187327,"median":15.718602,"eighty":17.818141,"marketCap":79931945},{"date":"2024-05-31","current":-13.721878,"twenty":13.545619,"median":15.079879,"eighty":17.786209,"marketCap":79931945},{"date":"2024-06-07","current":-14.08298,"twenty":12.926135,"median":14.744671,"eighty":17.776629,"marketCap":82035417},{"date":"2024-06-14","current":-14.564515,"twenty":-13.557216,"median":14.673941,"eighty":17.770243,"marketCap":84840426},{"date":"2024-06-21","current":-15.922863,"twenty":-13.825876,"median":14.209648,"eighty":17.731924,"marketCap":92753004},{"date":"2024-06-28","current":-12.919404,"twenty":-13.944317,"median":14.209648,"eighty":17.655287,"marketCap":75257414},{"date":"2024-07-05","current":-11.364849,"twenty":-13.990538,"median":14.209648,"eighty":17.52973,"marketCap":66201907},{"date":"2024-07-12","current":-11.153551,"twenty":-13.799876,"median":13.810656,"eighty":17.339222,"marketCap":64971062},{"date":"2024-07-15","current":-13.477836,"twenty":-13.773877,"median":13.571165,"eighty":17.280659,"marketCap":78510363},{"date":"2024-08-02","current":-12.964682,"twenty":-13.747877,"median":13.539233,"eighty":17.222095,"marketCap":75521166},{"date":"2024-08-09","current":-11.364095,"twenty":-13.723872,"median":13.251843,"eighty":17.027373,"marketCap":66197511},{"date":"2024-08-16","current":-8.441425,"twenty":-13.721878,"median":2.384851,"eighty":16.171527,"marketCap":59150297},{"date":"2024-08-23","current":-10.330099,"twenty":-13.617881,"median":-8.582039,"eighty":15.966076,"marketCap":72384510},{"date":"2024-08-30","current":-10.13985,"twenty":-13.52255,"median":-9.00413,"eighty":15.966076,"marketCap":71051408},{"date":"2024-09-06","current":-10.104487,"twenty":-13.488788,"median":-9.975078,"eighty":15.85112,"marketCap":70803616},{"date":"2024-09-13","current":-7.831133,"twenty":-13.268937,"median":-9.379361,"eighty":15.707426,"marketCap":54873890},{"date":"2024-09-20","current":-7.554188,"twenty":-13.112179,"median":-8.839249,"eighty":15.365752,"marketCap":52933298},{"date":"2024-09-27","current":-9.43006,"twenty":-13.019016,"median":-9.049816,"eighty":15.0623,"marketCap":66077809},{"date":"2024-10-04","current":-8.251303,"twenty":-12.937515,"median":-8.845695,"eighty":14.905865,"marketCap":57818083},{"date":"2024-10-11","current":-8.580848,"twenty":-12.554189,"median":-8.732946,"eighty":14.786183,"marketCap":60127254},{"date":"2024-10-18","current":-9.769745,"twenty":-12.214089,"median":-8.764633,"eighty":14.702233,"marketCap":68458031},{"date":"2024-10-25","current":-8.872369,"twenty":-11.941393,"median":-8.872369,"eighty":14.673941,"marketCap":62169982},{"date":"2024-10-31","current":-8.568173,"twenty":-11.747964,"median":-8.847019,"eighty":14.628789,"marketCap":60038439},{"date":"2024-11-08","current":-5.742165,"twenty":-11.5456,"median":-8.764633,"eighty":14.420496,"marketCap":40236191},{"date":"2024-11-15","current":-6.048407,"twenty":-11.364849,"median":-8.720054,"eighty":14.209648,"marketCap":44459880},{"date":"2024-11-22","current":-5.928673,"twenty":-11.364547,"median":-8.695365,"eighty":14.209648,"marketCap":43570682},{"date":"2024-11-29","current":-6.352149,"twenty":-11.321986,"median":-8.600455,"eighty":14.209648,"marketCap":46682874},{"date":"2024-12-06","current":-7.456945,"twenty":-11.110513,"median":-8.568173,"eighty":14.187327,"marketCap":54802179},{"date":"2024-12-13","current":-6.006451,"twenty":-10.914992,"median":-8.561836,"eighty":14.088465,"marketCap":44142287},{"date":"2024-12-20","current":-7.07266,"twenty":-10.789111,"median":-8.479449,"eighty":13.954351,"marketCap":51978012},{"date":"2024-12-27","current":-6.747673,"twenty":-10.659517,"median":-8.390726,"eighty":13.571165,"marketCap":49589633},{"date":"2025-01-03","current":-6.517639,"twenty":-10.562175,"median":-8.162579,"eighty":13.520073,"marketCap":47899077},{"date":"2025-01-10","current":-5.904214,"twenty":-10.499761,"median":-8.051056,"eighty":13.363605,"marketCap":43390929},{"date":"2025-01-17","current":-6.07035,"twenty":-10.463782,"median":-7.83254,"eighty":13.258229,"marketCap":44611886},{"date":"2025-01-24","current":-6.006451,"twenty":-10.451708,"median":-7.712623,"eighty":13.14966,"marketCap":44142287},{"date":"2025-01-31","current":-5.878654,"twenty":-10.421318,"median":-7.617562,"eighty":12.926135,"marketCap":43203089},{"date":"2025-02-07","current":-5.878654,"twenty":-10.364245,"median":-7.402632,"eighty":5.571028,"marketCap":43203089},{"date":"2025-02-14","current":-5.955332,"twenty":-10.299629,"median":-7.207741,"eighty":-5.38422,"marketCap":43766608},{"date":"2025-02-21","current":-6.249265,"twenty":-10.231108,"median":-7.041606,"eighty":-5.510713,"marketCap":45926762},{"date":"2025-02-28","current":-6.380056,"twenty":-10.13985,"median":-6.713492,"eighty":-5.574659,"marketCap":46887966},{"date":"2025-03-07","current":-6.326216,"twenty":-10.13478,"median":-6.696682,"eighty":-5.743169,"marketCap":46492287},{"date":"2025-03-14","current":-5.532074,"twenty":-10.112497,"median":-6.684888,"eighty":-5.743169,"marketCap":40656021},{"date":"2025-03-21","current":-6.110856,"twenty":-10.104487,"median":-6.616553,"eighty":-5.743169,"marketCap":44909571},{"date":"2025-03-28","current":-4.234631,"twenty":-10.098885,"median":-6.511249,"eighty":-5.532216,"marketCap":47178021},{"date":"2025-04-04","current":-4.894342,"twenty":-10.073941,"median":-6.460817,"eighty":-4.926436,"marketCap":54527860},{"date":"2025-04-11","current":-4.279206,"twenty":-10.051126,"median":-6.404799,"eighty":-4.716041,"marketCap":47674632},{"date":"2025-04-17","current":-4.680381,"twenty":-10.000427,"median":-6.391338,"eighty":-4.680381,"marketCap":52144128},{"date":"2025-04-25","current":-5.429242,"twenty":-9.949728,"median":-6.352149,"eighty":-4.680381,"marketCap":60487189},{"date":"2025-05-02","current":-4.733871,"twenty":-9.769745,"median":-6.319486,"eighty":-4.680381,"marketCap":52740061},{"date":"2025-05-09","current":-5.121942,"twenty":-9.696231,"median":-6.287604,"eighty":-4.698211,"marketCap":57063554},{"date":"2025-05-16","current":-59.867974,"twenty":-10.063801,"median":-6.319486,"eighty":-4.716041,"marketCap":56216028},{"date":"2025-05-23","current":-62.521698,"twenty":-10.1145,"median":-6.352149,"eighty":-4.716041,"marketCap":58707874},{"date":"2025-05-30","current":-61.035612,"twenty":-10.269158,"median":-6.380056,"eighty":-4.730305,"marketCap":57312440},{"date":"2025-06-06","current":-63.15859,"twenty":-10.460251,"median":-6.404799,"eighty":-4.739577,"marketCap":59305916},{"date":"2025-06-13","current":-62.893218,"twenty":-10.844881,"median":-6.460817,"eighty":-4.756693,"marketCap":59056732},{"date":"2025-06-20","current":-61.035612,"twenty":-11.364397,"median":-6.504859,"eighty":-4.787361,"marketCap":57312440},{"date":"2025-06-27","current":-65.069271,"twenty":-11.941393,"median":-6.601297,"eighty":-4.858682,"marketCap":61100045},{"date":"2025-07-03","current":-63.052442,"twenty":-12.946571,"median":-6.683774,"eighty":-4.897908,"marketCap":59206243},{"date":"2025-07-11","current":-62.585387,"twenty":-13.494265,"median":-6.687561,"eighty":-4.963879,"marketCap":58767678},{"date":"2025-07-18","current":-56.365062,"twenty":-13.727859,"median":-6.706215,"eighty":-5.054812,"marketCap":52926793},{"date":"2025-07-25","current":-57.320401,"twenty":-14.163867,"median":-6.747673,"eighty":-5.06551,"marketCap":53823857},{"date":"2025-08-01","current":-58.806486,"twenty":-14.540367,"median":-7.140201,"eighty":-5.097711,"marketCap":55219290},{"date":"2025-08-08","current":-57.851146,"twenty":-16.339423,"median":-7.348318,"eighty":-5.123618,"marketCap":54322226},{"date":"2025-08-15","current":-4.477661,"twenty":-17.151414,"median":-7.290809,"eighty":-5.06551,"marketCap":56378234},{"date":"2025-08-22","current":-4.477661,"twenty":-16.339423,"median":-7.07266,"eighty":-4.840851,"marketCap":56378234},{"date":"2025-08-29","current":-4.176437,"twenty":-15.621008,"median":-6.732661,"eighty":-4.723173,"marketCap":52585516},{"date":"2025-09-05","current":-4.298555,"twenty":-15.168225,"median":-6.706215,"eighty":-4.683947,"marketCap":54123104},{"date":"2025-09-12","current":-4.152013,"twenty":-15.047483,"median":-6.687561,"eighty":-4.603418,"marketCap":52277998},{"date":"2025-09-19","current":-3.671682,"twenty":-14.552441,"median":-6.683774,"eighty":-4.480762,"marketCap":46230151},{"date":"2025-09-26","current":-4.054319,"twenty":-14.495088,"median":-6.586042,"eighty":-4.445795,"marketCap":51047928},{"date":"2025-10-03","current":-4.274131,"twenty":-14.455909,"median":-6.482838,"eighty":-4.363684,"marketCap":53815587},{"date":"2025-10-10","current":-4.670023,"twenty":-14.397862,"median":-6.433897,"eighty":-4.347636,"marketCap":58800259},{"date":"2025-10-17","current":-4.092547,"twenty":-14.188422,"median":-6.402621,"eighty":-4.323139,"marketCap":51529260},{"date":"2025-10-24","current":-4.322701,"twenty":-14.088758,"median":-6.364249,"eighty":-4.310147,"marketCap":54427122},{"date":"2025-10-31","current":-4.008855,"twenty":-14.036759,"median":-6.339182,"eighty":-4.297619,"marketCap":50475491},{"date":"2025-11-07","current":-3.448117,"twenty":-13.827869,"median":-6.299296,"eighty":-4.264361,"marketCap":43415245},{"date":"2025-11-14","current":-3.280733,"twenty":-13.729853,"median":-6.273601,"eighty":-4.236343,"marketCap":41307709},{"date":"2025-11-21","current":-2.15737,"twenty":-13.721878,"median":-6.249265,"eighty":-4.197811,"marketCap":40096880},{"date":"2025-11-28","current":-2.444254,"twenty":-13.721878,"median":-6.245456,"eighty":-4.152013,"marketCap":45428912},{"date":"2025-12-05","current":-1.990977,"twenty":-13.591882,"median":-6.147028,"eighty":-4.102049,"marketCap":37004302},{"date":"2025-12-12","current":-1.801633,"twenty":-13.505217,"median":-6.121468,"eighty":-4.090954,"marketCap":33485160},{"date":"2025-12-19","current":-1.524503,"twenty":-13.477836,"median":-6.11051,"eighty":-4.06246,"marketCap":28334418},{"date":"2025-12-26","current":-1.399995,"twenty":-13.199304,"median":-6.089519,"eighty":-4.041726,"marketCap":26020316},{"date":"2026-01-02","current":-1.097619,"twenty":-13.112179,"median":-6.083129,"eighty":-3.997732,"marketCap":20400354},{"date":"2026-01-09","current":-1.503274,"twenty":-13.019016,"median":-6.07035,"eighty":-3.774262,"marketCap":27939847},{"date":"2026-01-16","current":-1.543438,"twenty":-12.937515,"median":-6.048407,"eighty":-3.438074,"marketCap":28686332},{"date":"2026-01-23","current":-1.698355,"twenty":-12.675928,"median":-6.046598,"eighty":-3.349361,"marketCap":31565629},{"date":"2026-01-30","current":-2.031141,"twenty":-12.246297,"median":-6.019231,"eighty":-2.444254,"marketCap":37750786},{"date":"2026-02-06","current":-1.433355,"twenty":-12.01082,"median":-6.006451,"eighty":-2.225304,"marketCap":26640343},{"date":"2026-02-13","current":-0.98652,"twenty":-11.747964,"median":-6.006451,"eighty":-2.15737,"marketCap":18335458},{"date":"2026-02-20","current":-1.003929,"twenty":-11.605851,"median":-5.962795,"eighty":-2.0036,"marketCap":18659025},{"date":"2026-02-27","current":-1.050353,"twenty":-11.364849,"median":-5.922833,"eighty":-1.871633,"marketCap":19521870},{"date":"2026-03-06","current":-0.91108,"twenty":-11.364698,"median":-5.904214,"eighty":-1.792453,"marketCap":16933335},{"date":"2026-03-13","current":-0.905277,"twenty":-11.321986,"median":-5.880344,"eighty":-1.689175,"marketCap":16825479},{"date":"2026-03-20","current":-1.439158,"twenty":-11.110513,"median":-5.878654,"eighty":-1.646716,"marketCap":26748198},{"date":"2026-03-27","current":-1.467538,"twenty":-10.914992,"median":-5.860708,"eighty":-1.608363,"marketCap":28150322},{"date":"2026-04-02","current":-1.360964,"twenty":-10.82151,"median":-5.792072,"eighty":-1.560651,"marketCap":26106017},{"date":"2026-04-10","current":-1.283929,"twenty":-10.659517,"median":-5.747183,"eighty":-1.531962,"marketCap":24628318},{"date":"2026-04-17","current":-1.277509,"twenty":-10.537839,"median":-5.619103,"eighty":-1.503274,"marketCap":24505176},{"date":"2026-04-24","current":-1.245411,"twenty":-10.474376,"median":-5.532074,"eighty":-1.457259,"marketCap":23889468},{"date":"2026-05-01","current":-1.168375,"twenty":-10.45672,"median":-5.366406,"eighty":-1.411471,"marketCap":22411769},{"date":"2026-05-08","current":-1.405823,"twenty":-10.444191,"median":-5.170707,"eighty":-1.405823,"marketCap":26966496},{"date":"2026-05-15","current":-1.33592,"twenty":-10.387009,"median":-5.152877,"eighty":-1.38852,"marketCap":25625621},{"date":"2026-05-22","current":-1.32194,"twenty":-10.330099,"median":-5.121942,"eighty":-1.360964,"marketCap":28113690},{"date":"2026-05-29","current":-1.366074,"twenty":-10.269158,"median":-5.054812,"eighty":-1.357002,"marketCap":29052303},{"date":"2026-06-05","current":-1.303025,"twenty":-10.162665,"median":-4.898799,"eighty":-1.332617,"marketCap":27711427},{"date":"2026-06-12","current":-1.267997,"twenty":-10.13985,"median":-4.760616,"eighty":-1.316834,"marketCap":26966496},{"date":"2026-06-18","current":-1.387091,"twenty":-10.12464,"median":-4.733871,"eighty":-1.316632,"marketCap":29499261},{"date":"2026-06-26","current":-1.283465,"twenty":-10.108492,"median":-4.713955,"eighty":-1.313459,"marketCap":27295459},{"date":"2026-07-02","current":-1.353985,"twenty":-10.104487,"median":-4.689296,"eighty":-1.312175,"marketCap":28795209},{"date":"2026-07-10","current":-1.551442,"twenty":-10.093283,"median":-4.680381,"eighty":-1.316431,"marketCap":32994511},{"date":"2026-07-17","current":-1.396298,"twenty":-10.071406,"median":-4.608878,"eighty":-1.318089,"marketCap":29695059},{"date":"2026-07-24","current":-1.47387,"twenty":-10.038451,"median":-4.546656,"eighty":-1.320577,"marketCap":31344785},{"date":"2026-07-31","current":-1.43861,"twenty":-9.990287,"median":-4.493166,"eighty":-1.323761,"marketCap":30594910},{"date":"2026-08-07","current":-1.657222,"twenty":-9.913731,"median":-4.473591,"eighty":-1.331403,"marketCap":35244136},{"date":"2026-08-14","current":-2.009822,"twenty":-9.755042,"median":-4.445096,"eighty":-1.33332,"marketCap":42742889},{"date":"2026-08-21","current":-3.178808,"twenty":-9.673416,"median":-4.399188,"eighty":-1.335413,"marketCap":67311253}],"updateTime":1787460924410},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SER\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660491247","title":"Serina Therapeutics: Buy Rating Reiterated, $11 Price Target Maintained on Strong SER-252 Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491247","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660491247?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:55","pubTimestamp":1787079320,"startTime":"0","endTime":"0","summary":"Analyst Justin Walsh of JonesTrading reiterated a Buy rating on Serina Therapeutics, retaining the price target of $11.00. Justin Walsh has given h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/serina-therapeutics-buy-rating-reiterated-11-price-target-maintained-on-strong-ser-252-clinical-progress-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/serina-therapeutics-buy-rating-reiterated-11-price-target-maintained-on-strong-ser-252-clinical-progress-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SER","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162770","title":"Serina Therapeutics, Inc Q2 Operating Expenses USD 6.784 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162770","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162770?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nPLXC0CLLT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162509","title":"Serina Therapeutics Q2 FY26 Net Loss Narrows to $6.36 Million; Revenue Falls to no Grant Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162509","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162509?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651554,"startTime":"0","endTime":"0","summary":"Serina Therapeutics Q2 FY26 net loss narrows to $6.36 million; revenue falls to no grant revenueSerina Therapeutics posted a net loss of USD 6.36 million in the quarter ended June 30, 2026, narrowing ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL6nppK6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655383672","title":"Serina Therapeutics Posts Investor Deck Outlining POZ Platform, Lead Parkinson’s Candidate Ser-252 Phase 1b Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2655383672","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655383672?lang=en_us&edition=fundamental","pubTime":"2026-07-29 07:09","pubTimestamp":1785280190,"startTime":"0","endTime":"0","summary":"Serina Therapeutics posts investor deck outlining POZ platform, lead Parkinson’s candidate SER-252 Phase 1b studySerina outlined a milestone-driven CNS strategy centered on lead program SER-252, a POZ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL6vstg9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653085851","title":"Serina Therapeutics to Join BTIG Virtual Biotechnology Conference Investor Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2653085851","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653085851?lang=en_us&edition=fundamental","pubTime":"2026-07-24 18:01","pubTimestamp":1784887263,"startTime":"0","endTime":"0","summary":"Serina Therapeutics to join BTIG Virtual Biotechnology Conference investor meetingsSerina Therapeutics will participate in the BTIG Virtual Biotechnology Conference on July 28-29, 2026.Management is s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDL18dgvg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BCDF","LU2095319765.USD","BK4588","IE00B64PRP62.GBP","SG9999014005.SGD","NDAQ","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","SER","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014039.USD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","SG9999014013.SGD","BK4139","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653710817","title":"Serina Therapeutics Director Simon Farrell Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2653710817","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653710817?lang=en_us&edition=fundamental","pubTime":"2026-07-24 06:49","pubTimestamp":1784846999,"startTime":"0","endTime":"0","summary":"Serina Therapeutics director Simon Farrell files initial beneficial ownership statementSerina Therapeutics director Simon Farrell filed an initial Form 3 on July 23, 2026.Disclaimer:This news brief wa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL2NJ1K5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653776769","title":"Serina Therapeutics CEO Steve Ledger Base Salary Rises to $500,000 Under Amended Employment Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2653776769","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653776769?lang=en_us&edition=fundamental","pubTime":"2026-07-24 05:00","pubTimestamp":1784840436,"startTime":"0","endTime":"0","summary":"Serina Therapeutics CEO Steve Ledger base salary rises to $500,000 under amended employment dealSerina Therapeutics entered an amended and restated employment agreement with CEO Steve Ledger on July 19, 2026.Sets annual base salary at USD 500,000; target annual bonus set at 50% of base salary.Without-cause termination or good-reason resignation outside a change in control triggers 12 months base salary, pro-rated target bonus, 12 months COBRA.Qualifying change-in-control termination triggers 1.5x base salary, 1.5x target bonus, pro-rated target bonus, 18 months COBRA.Change-in-control terms include full accelerated vesting of unvested time-based equity awards; parachute benefits subject to best-net reduction, no excise-tax gross-up.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL48ftBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653130745","title":"Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of Ser-252 for Advanced Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2653130745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653130745?lang=en_us&edition=fundamental","pubTime":"2026-07-23 18:00","pubTimestamp":1784800802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nTUA9B49LK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653746570","title":"Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2653746570","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653746570?lang=en_us&edition=fundamental","pubTime":"2026-07-23 18:00","pubTimestamp":1784800800,"startTime":"0","endTime":"0","summary":"- All eight patients enrolled and dosed in Cohort 1 ahead of previously disclosed guidance of the end of the third quarter of 2026 - - Independent Safety Monitoring Committee to review Cohort 1 safety","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/23/3331950/0/en/Serina-Therapeutics-Announces-Completion-of-Enrollment-and-Dosing-in-Cohort-1-of-Registrational-Trial-of-SER-252-for-Advanced-Parkinson-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK4139","AEIS","LU0757428866.USD","IE0031619046.USD","SER","BK4157","IE00B7SZL793.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653951627","title":"Serina Therapeutics Appoints Trevi CCO Farrell Simon to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2653951627","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653951627?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:39","pubTimestamp":1784752762,"startTime":"0","endTime":"0","summary":"Serina Therapeutics appoints Trevi CCO Farrell Simon to boardSerina Therapeutics named Farrell Simon to its board, effective immediately.Simon will join the audit committee, plus the compensation comm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL7FCXjv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014021.USD","IE00BN0W2W23.USD","BK4007","SG9999014039.USD","IE00BKPKM429.USD","NDAQ","IE00BGHQF748.EUR","BK4585","BCDF","LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4139","SER","SG9999014005.SGD","LU0314104364.USD","SG9999014013.SGD","TRVI","BK4588","BK4112","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653579307","title":"Serina Therapeutics Appoints Farrell Simon to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2653579307","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653579307?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:30","pubTimestamp":1784752200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUA6YRL3N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650754409","title":"Serina Says Panel Clears Dosing More Patients in Phase 1b Trial of SER-252 in Parkinson's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2650754409","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650754409?lang=en_us&edition=fundamental","pubTime":"2026-07-10 00:40","pubTimestamp":1783615201,"startTime":"0","endTime":"0","summary":"Serina Therapeutics  said Thursday the independent safety monitoring committee for its phase 1b trial of SER-252 in patients with advanced Parkinson's disease recommended dosing additional patients after a review of the initial 72-hour safety and tolerability data from the sentinel dosing group.The company said additional patient dosing in cohort 1 of the study is now taking place at clinical sites in the US and Australia.Serina said it now expects to complete enrollment and dosing of cohort 1 ahead of its previous guidance to finish by the end of Q3.SER 252 is an investigational apomorphine therapy developed with Serina's POZ platform and designed to provide continuous dopaminergic stimulation, which has been known to reduce the severity of levodopa-related motor complications in Parkinson's disease, the company said.Shares of Serina Therapeutics rose more than 9% in Thursday trading.Price: 2.19, Change: +0.19, Percent Change: +9.50","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SER","BK4139","BK7095","SER.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650975300","title":"Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1B Registrational Trial of Ser-252 for Advanced Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2650975300","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650975300?lang=en_us&edition=fundamental","pubTime":"2026-07-10 00:10","pubTimestamp":1783613400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nTUA7WDVQ4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650097580","title":"Serina Therapeutics Director Stephen K. Brannan Acquires 1,000 Common Shares Worth $2,030","url":"https://stock-news.laohu8.com/highlight/detail?id=2650097580","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650097580?lang=en_us&edition=fundamental","pubTime":"2026-07-10 00:05","pubTimestamp":1783613143,"startTime":"0","endTime":"0","summary":"Serina Therapeutics director Stephen K. Brannan acquires 1,000 common shares worth $2,030Serina Therapeutics director Stephen K. Brannan bought 1,000 common shares at USD 2.03 each.Brannan’s direct ho","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL9n3KT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Serina Therapeutics Director Stephen K. Brannan Acquires 1,000 Common Shares Worth $2,030","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649699345","title":"Seres Therapeutics' Phase 1 Trial of SER-155 Meets Primary Endpoint; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2649699345","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649699345?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:55","pubTimestamp":1783511748,"startTime":"0","endTime":"0","summary":"Seres Therapeutics  said Wednesday that top-line results from a phase 1 clinical trial of SER-155 to treat patients with immune checkpoint inhibitor-related enterocolitis met its primary endpoint.The primary endpoint was defined as at least a 1-grade improvement in diarrhea symptoms without immunosuppressive therapy, such as a corticosteroid and/or a biologic immunomodulator drug.Inhibitor-related enterocolitis, or irEC, is a frequent side effect of immune checkpoint inhibitors that often causes patients to halt cancer treatment.\"Patients receiving ICI treatment who develop irEC face significant challenges, as current management often necessitates interruption or discontinuation of checkpoint inhibitor therapy and treatment with systemic immunosuppressives, which are associated with clinically significant side effects,\" Principal Investigator David Faleck said in a statement.Shares of Seres Therapeutics were up more than 6% pre-bell.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MCRB","SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649099825","title":"Seres Therapeutics announces top-line results from SER-155 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2649099825","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649099825?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:20","pubTimestamp":1783509616,"startTime":"0","endTime":"0","summary":"Seres Therapeutics (MCRB) announced top-line results from an investigator-sponsored trial evaluating SER-155 in patients with irEC. The study, cond...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seres-therapeutics-announces-top-line-results-from-ser-155-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seres-therapeutics-announces-top-line-results-from-ser-155-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SER","MCRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649896003","title":"Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2649896003","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649896003?lang=en_us&edition=fundamental","pubTime":"2026-07-08 19:00","pubTimestamp":1783508400,"startTime":"0","endTime":"0","summary":"80% of SER-155 recipients achieved immunosuppressive-free clinical response of diarrhea (a primary symptom of irEC) at Day 15 in the Investigator-Sponsored Trial (IST) conducted by Memorial Sloan Kett","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3323958/0/en/Seres-Therapeutics-Announces-Early-Clinical-Data-Showing-Potential-for-SER-155-in-Immune-Checkpoint-Inhibitor-Related-Enterocolitis-irEC-a-Frequent-Adverse-Reaction-That-Forces-Man.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCRB","SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648208815","title":"Sumitomo Backs $1m Exploration Push at SER’s Bulimba Gold Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2648208815","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648208815?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:35","pubTimestamp":1782952542,"startTime":"0","endTime":"0","summary":"Strategic Energy Resources Limited ( ($AU:SER) ) just unveiled an announcement. Strategic Energy Resources has secured approval from joint venture ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sumitomo-backs-1m-exploration-push-at-sers-bulimba-gold-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sumitomo-backs-1m-exploration-push-at-sers-bulimba-gold-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648519017","title":"Serina Therapeutics initiated with a Buy at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2648519017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648519017?lang=en_us&edition=fundamental","pubTime":"2026-07-01 17:30","pubTimestamp":1782898210,"startTime":"0","endTime":"0","summary":"BTIG analyst Thomas Shrader initiated coverage of Serina Therapeutics (SER) with a Buy rating and $8 price target Serina is a clinical stage biotec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/serina-therapeutics-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SER","BK4539","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647559558","title":"Gannet Biochem and Serina Therapeutics Enter Development Partnership Supporting Ser-252 Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2647559558","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647559558?lang=en_us&edition=fundamental","pubTime":"2026-06-30 21:04","pubTimestamp":1782824691,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nFWN432107:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":59,"code":"91000000","status":"200"}]}}